Main Street Financial Solutions’s Verve Therapeutics VERV Stock Holding History

Main Street Financial Solutions’s Portfolio VERV Stock Details VERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,211	Closed	-$193K	–	641
2025 Q2	$193K	Buy	+17,211	New	+$98.1K	0.01%	528

Other funds holding VERV

GCM

Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Main Street Financial Solutions's VERV Position: Q3 2025 in Review

Main Street Financial Solutions sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 17,211 shares — an estimated $193K sold.

Main Street Financial Solutions first reported a position in VERV in Q2 2025 and held it in 1 quarter. The position peaked at $193K in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

Main Street Financial Solutions reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
Main Street Financial Solutions sold 17,211 Verve Therapeutics shares in Q3 2025, an estimated $193K.
Main Street Financial Solutions first reported a position in Verve Therapeutics in Q2 2025 and held it in 1 quarter.
Main Street Financial Solutions's Verve Therapeutics position peaked at $193K in Q2 2025.
6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Main Street Financial Solutions's 13F filing for Q3 2025, filed 14 Nov 2025.